November 23, 2015
Geistlich Pharma recalls Decalcit chewing tablets due to Italian version typo
The Swiss-based company Geistlich Pharma AG is recalling batch of Decalcit, vitamin D and calcium chewable tablets, from the market.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
November 20, 2015
Bayer submits its new five-year-contraceptive for EU and US marketing Authorization
Bayer has submitted an application for marketing authorization in both the European Union and in the United States for LCS-16, a new low-dose levonorgestrel-releasing intrauterine system
November 20, 2015
Sanofi and AstraZeneca to share compound libraries
Sanofi and AstraZeneca have announced a direct exchange of 210,000 compounds from their respective, proprietary compound libraries.
November 20, 2015
Mylan in patent lawsuit
Mylan’s subsidiaries were sued Warner Chilcott and Qualicaps in connection with the filing of an ANDA with the FDA for Mesalamine Delayed-release Capsules.
November 19, 2015
Lilly and Merck move on with oncology clinical trial of and Keytruda
Eli Lilly and Merck are moving on with an existing oncology clinical trial collaboration to evaluate the safety and efficacy of the combination of Lilly’s Almita (pemetrexed for injection) and Merck’s Keytruda (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).
November 19, 2015
Sanofi CEO: Health must be part of the Climate debate
Sanofi will participate to Solutions COP21, the United Nations conference on climate change, as an official partner, a public exhibition in Paris.
November 19, 2015
Biofrontera concludes clinical phase III of BCC study. Approval of Ameluz expected in 2016
Biofrontera has concluded the clinical phase 3 of BCC study as the last patient in the ongoing phase has had its final clinical visit.
November 18, 2015
UK cost watchdog turns down Amgen’s new cholesterol drug
Amgen’s new injectable cholesterol drug Repatha has been turned down for use on Britain’s state health service, underscoring a worldwide debate about the value of such pricey medicines.
November 18, 2015
Advanced Oncotherapy disposes of its subsiadiary for £100K
Advanced Oncotherapy has disposed of its subsidiary, Oncotherapy Resources Ltd (ORL), for a total cash consideration of £100,000 to Xstrahl.…
November 18, 2015
Vertex gets EU approval for expanded use of its cystic fibrosis drug Kalydeco
The European Commission has approved expansion of the indication for Vertex Pharmaceuticals’ Kalydeco, to include children ages 2-5 with cystic fibrosis…